Brief: Evolus Q3 Product Revenue USD 68.967 Million
05/11/2025 21:05
Nov 05 (Reuters) - Evolus Q3 net income USD -15.737 million. Q3 gross margin 66.5% Q3 adjusted gross margin 67.6% Q3 gross profit USD 45.841 million outlook FY sales USD 295-305 million
Recent news on Evolus
See all newsEvolus Inc reports results for the quarter ended June 30 - Earnings Summary
Evolus Q2 revenue rises 21%, lifts 2026 outlook
Brief: Evolus Q2 Product Revenue USD 83.35 Million
Evolus Inc expected to post a loss of 3 cents a share - Earnings Preview
Brief: Evolus Announces Commercial Launch Of Estyme® Injectable Hyaluronic Acid Gels In Europe